Research
ATN166: Combatting HIV or Other STIs Early (CHOOSE)
The CHOOSE study is evaluating (1) whether a package of digital health tools will help young men choose which type of PrEP to take and take it as recommend and (2) who will take doxycycline for STI prevention when offered it and whether they will take it as recommended. The CHOOSE study hopes to break the cycle of high rates of new HIV and STI diagnoses among young people.
Help us build health solutions by and for young people by participating in an ATN research study. We’re enrolling youth ages 13-24 nationwide in paid studies!
ATN173: Doxycycline to Prevent STIs in Young Females
The foXXy doxy study is researching whether DoxyPEP, an antibiotic approved for STI prevention among men, is effective at reducing STIs among women. Get up to $400 for taking DoxyPEP as prescribed and completing 7 study visits, some of which include STI testing.
- Learn more about ATN 173: foXXy doxy and find out if you qualify >
- Contact a St. Jude Research staff member: (901) 216-1166
- Refer a patient for this study >
Predicting Risk & Observing Trends in the Epidemiology of HIV after policy Changes in Tennessee (PROTECT-TN) Study
In January 2023, it was announced that Tennessee state would reject nearly $9 million in federal funding for HIV testing and prevention, effective June 1, 2023. The public health impact of rejecting federal funding for community-based HIV services in Tennessee may be profound, with the potential to widen disparities in HIV testing and prevention services for racial, sexual/gender, and rural residential minorities. The overarching goal of this project is to provide a near-real-time evaluation of whether and how policy changes to funding HIV testing and prevention in Tennessee are affecting HIV outcomes, particularly among populations highly vulnerable to HIV. Although focused on Tennessee, results are relevant to broader policy discussions around the direction of federal funding to community-based organizations for public health programs already emerging across the US South.
For questions or comments, please email us at [email protected].